Share chart Clarity Pharmaceuticals Ltd
Extended chart
Simple chart
About Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. more detailsIndustry | Biotechnology |
---|---|
Sector | Health Care |
Валюта | usd |
Валюта отчета | aud |
Сайт | https://www.claritypharmaceuticals.com |
Цена ао | 1.5 |
Change price per day: | -6.78% (1.18) |
---|---|
Change price per week: | +17.02% (0.94) |
Change price per month: | -37.29% (1.754) |
Change price per 3 month: | -51.54% (2.27) |
Change price per half year: | -75.5% (4.49) |
Change price per year: | -42.11% (1.9) |
Change price per year to date: | -69.18% (3.569) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
PFM Multi Manager Series-International Equity Fd | 24827 | 0.01 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Alan John Taylor Ph.D. | Executive Chairman | 567.72k | |
Dr. Colin David Biggin Ph.D. | MD, CEO & Executive Director | 455.18k | |
Mr. David K. Green BEc., CA | Chief Financial Officer | 159.32k | |
Mr. Shaemus Gleason | Executive Vice President of Operations | N/A | |
Dr. Matthew Harris BSc., M.B.A., Ph.D. | Chief Scientific Officer | 130.94k | |
Michelle Parker | Chief Clinical Officer | N/A | |
Mr. Robert Vickery | Company Secretary | 109.28k | |
Ms. Lisa Sadetskaya | Director of Corporate Communications. | ||
Mary Bennett | Head of Human Resource | ||
Dr. Othon Gervasio | Chief Medical Officer |
Address: Australia, Sydney, National Innovation Centre - open in Google maps, open in Yandex maps
Website: https://www.claritypharmaceuticals.com
Website: https://www.claritypharmaceuticals.com